Poslední zkoušky

EudraCT Number: 2011-004417-16

Sponsor Protocol Number: 5022LC

Start Date:

Sponsor Name: St. Elisabeth Hospital

Full Title: CEFTRIAXONE NEONATAL THERAPY: A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF CEFTRIAXONE ON HYPERBILIRUBINEMIA

Medical condition: Hyperbilirubinemia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Preterm newborn infants, Newborns, Under 18

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-002705-19

Sponsor Protocol Number: OMPeR

Start Date:

Sponsor Name: FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO

Full Title: A phase IV, randomized, controlled, double-blind study on efficacy and safety of OM-85 in children with recurrent respiratory tract infections

Medical condition: Recurrent Respiratory Tract Infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	100000004862	10039249	RTI	LLT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-020047-12

Sponsor Protocol Number: P090202

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title: Etude de l'effet d'un traitement préventif par Nebivolol sur l'apparition et la progression de la dysfonction cardiaque chez les enfants atteints de dystrophie de Duchenne

Medical condition: Enfants atteints de dystrophie de Duchenne

Disease:	Version	SOC Term	Classification Code	Term	Level
	13.1	10010331 - Congenital, familial and genetic disorders	10013801	Duchenne muscular dystrophy	PT

Population Age: Children, Adolescents, Under 18

Gender: Male

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-002936-97

Sponsor Protocol Number: LTFU-ABO-101

Start Date:

Sponsor Name: Abeona Therapeutics Europe SL.

Full Title: A Long-term Follow-up Study of Patients with MPS IIIB from Gene Therapy Clinical Trials Involving the Administration of ABO-101 (rAAV9.CMV.hNAGLU)

Medical condition: MPS IIIB is a devastating lysosomal storage disease, caused by a N-α-acetylglucosaminidase (NAGLU) gene defect. Infants with MPS IIIB appear normal at birth, but the disease is relentlessly progres...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10010331 - Congenital, familial and genetic disorders	10056890	Mucopolysaccharidosis III	PT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-003801-15

Sponsor Protocol Number: 12011.202

Start Date:

Sponsor Name: PARIPharma GmbH

Full Title: A phase II, randomised, double-blind, placebo controlled, parallel group, dose-finding clinical trial to investigate the efficacy and safety of 10 and 20 mg/day aerosolised liposomal ciclosporin A ...

Medical condition: Bronchiolitis Obliterans Syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10049202	Bronchiolitis obliterans	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2010-023502-12

Sponsor Protocol Number: UCL 08/0350

Start Date:

Sponsor Name: University College London

Full Title: A Proof of Principle, Double-Blind, Randomised Placebo-Controlled,Multi-centre Trial of pravaStatin to Ameliorate Early Onset Pre-eclampsia

Medical condition: Pre-eclampsia

Disease:	Version	SOC Term	Classification Code	Term	Level
			10036485	Pre-eclampsia	LLT
			10040444	Severe pre-eclampsia	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2005-000928-17

Sponsor Protocol Number: A/201/05

Start Date:

Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Full Title: Hyperthermic intra-arterial chemotherapy with oxaliplatin in total hepatic vascular exclusion. A Phase II study

Medical condition: no resecable liver metastasis from colo-rectal and gastric cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10055114		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2014-004641-27

Sponsor Protocol Number: UZLeuven

Start Date:

Sponsor Name: UZLeuven

Full Title: BOTOX in the treatment of urinary incontinence due to neurogenic detrusor overactivity in patients 3 months - 17 years

Medical condition: Urinary incontinence due to neurogenic detrusor overactivity

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	10038359 - Renal and urinary disorders	10029279	Neurogenic bladder	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: BE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2014-000227-24

Sponsor Protocol Number: RG_13-320

Start Date:

Sponsor Name: University of Birmingham

Full Title: A Study of Thiotepa, Ifosphamide, Etoposide and Rituximab for the treatment of relapsed or refractory primary central nervous system lymphoma

Medical condition: Relapsed or refractory primary central neurvous system lymphoma.

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10007953	Central nervous system lymphoma	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2017-002383-40

Sponsor Protocol Number: ICC_APL_Study_02

Start Date:

Sponsor Name: AIEOP- Associazione Italiana Ematologia Oncologia Pediatrica

Full Title: Treatment study for children and adolescents with Acute Promyelocytic Leukemia

Medical condition: acute promyelocytic leukemia (APL) in children and adolescents

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

Poslední zkoušky

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence